Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Lack of evidence for CDK12 as an ovarian cancer predisposing gene.

Eeckhoutte A, Saint-Ghislain M, Reverdy M, Raynal V, Baulande S, Bataillon G, Golmard L, Stoppa-Lyonnet D, Popova T, Houdayer C, Manié E, Stern MH.

Fam Cancer. 2020 Mar 14. doi: 10.1007/s10689-020-00169-2. [Epub ahead of print]

PMID:
32172432
2.

Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus.

Roch M, Clair P, Renzoni A, Reverdy ME, Dauwalder O, Bes M, Martra A, Freydière AM, Laurent F, Reix P, Dumitrescu O, Vandenesch F.

Antimicrob Agents Chemother. 2014 Sep;58(9):5306-14. doi: 10.1128/AAC.02574-14. Epub 2014 Jun 23.

3.

Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.

Khanafer N, Touré A, Chambrier C, Cour M, Reverdy ME, Argaud L, Vanhems P.

World J Gastroenterol. 2013 Nov 28;19(44):8034-41. doi: 10.3748/wjg.v19.i44.8034.

4.

MRSA harboring mecA variant gene mecC, France.

Laurent F, Chardon H, Haenni M, Bes M, Reverdy ME, Madec JY, Lagier E, Vandenesch F, Tristan A.

Emerg Infect Dis. 2012 Sep;18(9):1465-7. doi: 10.3201/eid1809.111920.

5.

Detection of Staphylococcus aureus delta-toxin production by whole-cell MALDI-TOF mass spectrometry.

Gagnaire J, Dauwalder O, Boisset S, Khau D, Freydière AM, Ader F, Bes M, Lina G, Tristan A, Reverdy ME, Marchand A, Geissmann T, Benito Y, Durand G, Charrier JP, Etienne J, Welker M, Van Belkum A, Vandenesch F.

PLoS One. 2012;7(7):e40660. doi: 10.1371/journal.pone.0040660. Epub 2012 Jul 6.

6.

Validation of the BacT/ALERT®3D automated culture system for the detection of microbial contamination of epithelial cell culture medium.

Plantamura E, Huyghe G, Panterne B, Delesalle N, Thépot A, Reverdy ME, Damour O, Auxenfans C.

Cell Tissue Bank. 2012 Aug;13(3):453-9. doi: 10.1007/s10561-011-9281-1. Epub 2011 Dec 9.

PMID:
22160810
7.

Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients.

Filleron A, Chiron R, Reverdy ME, Jean-Pierre H, Dumitrescu O, Aleyrangues L, Counil F, Jumas-Bilak E, Marchandin H.

Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):599-604. doi: 10.1007/s10096-011-1353-4. Epub 2011 Sep 9.

PMID:
21904858
8.

Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients.

Filleron A, Chiron R, Reverdy ME, Jean-Pierre H, Dumitrescu O, Aleyrangues L, Counil F, Jumas-Bilak E, Marchandin H.

J Cyst Fibros. 2011 Sep;10(5):377-82. doi: 10.1016/j.jcf.2011.05.001. Epub 2011 Jun 1.

9.

In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Muller-Serieys C, Drugeon HB, Kitzis MD, Reverdy ME, Roussel-Delvallez M, Moubareck C, Brémont S, Miara A, Gjoklaj M, Soussy CJ.

Int J Antimicrob Agents. 2011 Mar;37(3):235-9. doi: 10.1016/j.ijantimicag.2010.11.035. Epub 2011 Feb 4.

10.

[Staphylococcus aureus resistance to antibiotics: key points in 2010].

Dumitrescu O, Dauwalder O, Boisset S, Reverdy MÉ, Tristan A, Vandenesch F.

Med Sci (Paris). 2010 Nov;26(11):943-9. doi: 10.1051/medsci/20102611943. Review. French.

11.

In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Armand-Lefevre L, Drugeon HB, Kitzis MD, Muller-Serieys C, Reverdy ME, Roussel-Delvallez M, Moubareck C, Lemire A, Miara A, Gjoklaj M, Soussy CJ.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):475-82. doi: 10.1007/s10096-010-1117-6. Epub 2010 Nov 19. Review.

12.

[How can we optimize medical orderings in intensive care unit (ICU)?].

Lehot JJ, Heuclin C, Neidecker J, Cartier R, Ffrench P, Reverdy ME, Revel D, Billard M, Lupo C, Gonnard B, Keller G, Aulagner G, Bastien O.

Ann Fr Anesth Reanim. 2010 Oct;29(10):682-6. doi: 10.1016/j.annfar.2010.06.017. Epub 2010 Aug 21. French.

PMID:
20729030
13.

Antimicrobial susceptibility profiles of Staphylococcus aureus isolated in 2007 from French patients with bloodstream infections: goodbye hVISA, welcome Geraldine?

Gallon O, Lamy B, Laurent F, Reverdy ME, Doucet-Populaire F, Decousser JW; Collège de Bactériologie Virologie Hygiène (ColBVH) Study Group.

J Antimicrob Chemother. 2010 Jun;65(6):1297-9. doi: 10.1093/jac/dkq128. Epub 2010 Apr 21. No abstract available.

PMID:
20410064
14.

Methicillin-resistant Staphylococcus aureus among a network of French private-sector community-based-medical laboratories.

Maugat S, de Rougemont A, Aubry-Damon H, Reverdy ME, Georges S, Vandenesch F, Etienne J, Coignard B.

Med Mal Infect. 2009 May;39(5):311-8. doi: 10.1016/j.medmal.2009.03.007. Epub 2009 Apr 22.

PMID:
19395210
15.

Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.

Dumitrescu O, Badiou C, Bes M, Reverdy ME, Vandenesch F, Etienne J, Lina G.

Clin Microbiol Infect. 2008 Apr;14(4):384-8. doi: 10.1111/j.1469-0691.2007.01947.x. Epub 2008 Feb 2.

16.

Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo.

Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, Etienne J.

Br J Dermatol. 2007 Dec;157(6):1161-7. Epub 2007 Oct 4.

PMID:
17916211
17.

Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.

Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, Courvalin P, Reverdy ME, Enright MC, Vandenesch F, Etienne J.

Emerg Infect Dis. 2007 Apr;13(4):594-600.

18.

Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin.

Dumitrescu O, Boisset S, Badiou C, Bes M, Benito Y, Reverdy ME, Vandenesch F, Etienne J, Lina G.

Antimicrob Agents Chemother. 2007 Apr;51(4):1515-9. Epub 2007 Jan 22.

19.

Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital.

Ramdani-Bouguessa N, Bes M, Meugnier H, Forey F, Reverdy ME, Lina G, Vandenesch F, Tazir M, Etienne J.

Antimicrob Agents Chemother. 2006 Mar;50(3):1083-5.

20.

Reducing contamination when removing and storing corneas: a multidisciplinary, transversal, and environmental approach.

Builles N, Perraud M, Reverdy ME, Burillon C, Crova P, Brun F, Chapuis F, Damour O.

Cornea. 2006 Feb;25(2):185-92.

PMID:
16371779
21.

Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II.

Verdier I, Reverdy ME, Etienne J, Lina G, Bes M, Vandenesch F.

Antimicrob Agents Chemother. 2004 Mar;48(3):1024-7.

22.

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J.

Emerg Infect Dis. 2003 Aug;9(8):978-84.

23.

Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms.

Haessler D, Reverdy ME, Neidecker J, Brûlé P, Ninet J, Lehot JJ.

J Cardiothorac Vasc Anesth. 2003 Apr;17(2):221-5.

PMID:
12698406
24.

[Rhône-Alpes observatory of Streptococcus pneumoniae in 1999: 35 cases of meningitis].

Chomarat M, Fredenucci I, Barbé G, Boucaud-Maitre Y, Boyer M, Carricajo A, Célard M, Clergeau P, Croizé J, Delubac F, Fèvre D, Fuhrmann C, Gilles Y, Gravagna B, Helfre M, Letouzey MN, Lelièvre H, Mandjee A, Marchal MF, Marthelet P, Meley R, Perrier-Gros-Claude JD, Bercion R, Reverdy ME, Ros A, Roure C, Sabot O, Smati S, Thierry J, Tixier A, Tous J, Verger P, Zaoui E.

Pathol Biol (Paris). 2002 Dec;50(10):595-8. French.

PMID:
12504368
25.

Multicenter evaluation of an automated system using selected bacteria that harbor challenging and clinically relevant mechanisms of resistance to antibiotics.

Leclercq R, Nicolas-Chanoine MH, Nordmann P, Philippon A, Marchais P, Buu-Ho A, Chardon H, Dabernat H, Doucet-Populaire F, Grasmick C, Legrand P, Muller-Serieys C, Nguyen J, Ploy MC, Reverdy ME, Weber M, Courcol RJ.

Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):626-35.

PMID:
11714043
26.

[Evaluation of the E-test and the ATB-PNEUMo battery for determining the beta-lactam MIC for Streptococcus pneumoniae in daily practice].

Chomarat M, Fredenucci I, Barbé G, Boucaud-Maitre Y, Boyer M, Carricajo A, Célard M, Clergeau P, Croizé J, Delubac F, Fèvre D, Fuhrmann C, Gilles Y, Gravagna B, Helfre M, Letouzey MN, Lelièvre H, Mandjee A, Marchal MF, Marthelet P, Meley R, Perrier-Gros-Claude JD, Bercion R, Reverdy ME, Ros A, Roure C, Sabot O, Smati S, Thierry J, Tixier A, Tous J, Verger P, Zaoui E.

Pathol Biol (Paris). 2001 Sep;49(7):548-52. French.

PMID:
11642017
27.
28.

Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals.

Reverdy ME, Jarraud S, Bobin-Dubreux S, Burel E, Girardo P, Lina G, Vandenesch F, Etienne J.

Clin Microbiol Infect. 2001 May;7(5):267-72.

29.

[Epidemic of Staphylococcus aureus nosocomial infections resistant to methicillin in a maternity ward].

Le Coq M, Simon I, Sire C, Tissot-Guerraz F, Fournier L, Aho S, Noblot G, Reverdy ME, Françoise M.

Pathol Biol (Paris). 2001 Feb;49(1):16-22. French.

PMID:
11265219
30.

[Indicators of quality for hospital antisepsis].

Tissot Guerraz F, Haond C, Reverdy ME, Freney J, Nicolle MC, Goullet D.

Pathol Biol (Paris). 2000 Oct;48(8):770-4. Review. French.

PMID:
11246481
31.

Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.

Bobin-Dubreux S, Reverdy ME, Nervi C, Rougier M, Bolmström A, Vandenesch F, Etienne J.

Antimicrob Agents Chemother. 2001 Jan;45(1):349-52.

32.

[Pneumococcus observatory data in the Rhône-Alps region. Results from 1996].

Thierry J, Perrier-Gros-Claude JD, Clavier B, Dumas M, Aubert G, Barbe G, Bland S, Boucaud-Maitre Y, Boyer M, Carricajo A, Chomarat M, Clergeau P, Delubac F, Fevre D, Fuhrmann C, Gravagnat B, Lelievre H, Letouzey MN, Mandjee A, Martelet P, Meley R, Reverdy ME, Ros A, Roure C, Tixier A, et al.

Pathol Biol (Paris). 1999 Dec;47(10):1060-4. French.

PMID:
10674259
33.

In vitro activity of fusidic acid against streptococci isolated from skin and soft tissue infections.

Leclercq R, Bismuth R, Casin I, Cavallo JD, Croizé J, Felten A, Goldstein F, Monteil H, Quentin-Noury C, Reverdy M, Vergnaud M, Roiron R.

J Antimicrob Chemother. 2000 Jan;45(1):27-9.

PMID:
10629009
34.

Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci.

Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J.

Antimicrob Agents Chemother. 1999 May;43(5):1062-6.

35.

Disseminated Rhodococcus equi and Nocardia farcinica infection in a patient with sarcoidosis.

Mohammedi I, Vedrinne JM, Floccard B, Reverdy ME, Duperret S, Motin J.

J Infect. 1998 Jan;36(1):134-5. No abstract available.

PMID:
9515692
36.

[Comparison of the results of the Etest and the method for determining minimum inhibitory concentrations in solid media for penicillin G, amoxicillin, and cefotaxime for S. pneumoniae. A multicenter study].

Clavier B, Perrier-Gros-Claude JD, Foissaud V, Dumas M, Aubert G, Barbé G, Bland S, Boucaud Maitre Y, Boyer M, Chomarat M, Clergeau P, Delubac F, Févre D, Fuhrmann C, Gravagnat B, Letouzey MN, Mandjee A, Martelet P, Meley R, Reverdy ME, Ros A, Roure C, Sabot O, Tixier A, Thierry J, et al.

Pathol Biol (Paris). 1998 Jun;46(6):369-74. French.

PMID:
9769863
37.

Kinetics of chlorhexidine on intact skin following a single application.

Carret L, Reverdy ME, Lafforgue C, Falson F, Fleurette J, Freney J.

Pathol Biol (Paris). 1997 Nov;45(9):737-40.

PMID:
9538472
38.

[Actinomyces meyeri disseminated actinomycosis disclosing pulmonary carcinoma].

Chaumentin G, Pariset C, Stouls T, Boibieux A, Reverdy ME, Baulieux J, Spitalier P, Biron F, Peyramond D.

Rev Med Interne. 1997 Jul;18(7):563-5. Review. French.

PMID:
9255374
39.
40.

[Kinetics of in vitro bactericidal activity of the antiseptic biseptine combining 3 active principles].

Reverdy ME, Rougier M, Fleurette J.

Pathol Biol (Paris). 1996 Sep;44(7):675-80. French.

PMID:
8977924
41.

Phenotypic and genotypic (pulsed-field gel electrophoresis) characteristics of enterotoxin-A-producing Staphylococcus aureus strains.

Gouloumès C, Bes M, Renaud F, Lina B, Reverdy ME, Brun Y, Fleurette J.

Res Microbiol. 1996 May;147(4):263-71.

PMID:
8763613
42.

[In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve].

Soussy CJ, Cluzel M, Derlot E, Exmelin L, Kitzis MD, Dabernat H, Le Noc P, Muller-Serieys C, Reverdy ME, Scheftel JM, Thabaut A.

Pathol Biol (Paris). 1996 Apr;44(4):241-8. French.

PMID:
8763585
43.

[Comparison of different phenotypic methods with polymerase chain reaction (PCR) for the detection of resistance to oxacillin in coagulase negative staphylococci].

Zambardi G, Lecoq M, Reverdy ME, Bes M, Freney J, Fleurette J.

Pathol Biol (Paris). 1995 Apr;43(4):310-4. French.

PMID:
7567121
44.

Non-puerperal breast infections due to Staphylococcus lugdunensis.

Lina B, Vandenesch F, Reverdy ME, Greenland T, Fleurette J, Etienne J.

Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):686-7. No abstract available.

PMID:
7813505
45.

Laboratory diagnosis of oxacillin resistance in Staphylococcus aureus by a multiplex-polymerase chain reaction assay.

Zambardi G, Reverdy ME, Bland S, Bes M, Freney J, Fleurette J.

Diagn Microbiol Infect Dis. 1994 May;19(1):25-31.

PMID:
7956009
46.

[Relationship between the level of minimal inhibitory concentrations of five antiseptics and the presence of qacA gene in Staphylococcus aureus].

Behr H, Reverdy ME, Mabilat C, Freney J, Fleurette J.

Pathol Biol (Paris). 1994 May;42(5):438-44. French.

PMID:
7824309
47.

[Nocardia asteroides meningitis without brain abscess in an non-immunodepressed adult].

Philit F, Boibieux A, Coppère B, Reverdy ME, Peyramond D, Bertrand JL.

Presse Med. 1994 Feb 19;23(7):346. French. No abstract available.

PMID:
8208698
48.

Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review.

Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ.

Clin Infect Dis. 1993 Nov;17(5):871-6. Review.

PMID:
8286628
49.

[Evolution of resistance to antibiotics and antiseptics of hospital Staphylococcus aureus strains isolated from 1980 to 1991].

Reverdy ME, Bes M, Brun Y, Fleurette J.

Pathol Biol (Paris). 1993 Nov;41(9):897-904. French.

PMID:
8121722
50.

[Evaluation of a micromethod for the bactericidal activity of five disinfectants on 108 hospital strains].

Dusseau JY, Chapalain JC, Rouby Y, Reverdy ME, Bartoli M.

Pathol Biol (Paris). 1993 Apr;41(4):349-57. French.

PMID:
8233634

Supplemental Content

Loading ...
Support Center